Let us create a wonderful future together！
This kit is used to quantitatively determine the content of pepsinogen Ⅱ (PG Ⅱ) in human serum in vitro.
Background of Clinical Indications
It is used for the auxiliary diagnosis of hepatopathy, atrophic gastritis and other diseases. PG Ⅱ has a greater correlation with gastric fundus mucosal lesions (compared to gastric antral mucosa), and its increase is related to gastric fundus gland atrophy, gastric epithelial metaplasia or Pseudopyloric gland metaplasia, and abnormal growth.